Jamal Hill

1.6k total citations
32 papers, 1.2k citations indexed

About

Jamal Hill is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jamal Hill has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Oncology and 11 papers in Genetics. Recurrent topics in Jamal Hill's work include Estrogen and related hormone effects (11 papers), Cancer-related Molecular Pathways (11 papers) and Retinoids in leukemia and cellular processes (6 papers). Jamal Hill is often cited by papers focused on Estrogen and related hormone effects (11 papers), Cancer-related Molecular Pathways (11 papers) and Retinoids in leukemia and cellular processes (6 papers). Jamal Hill collaborates with scholars based in United States, United Kingdom and Malaysia. Jamal Hill's co-authors include Powel H. Brown, Susan G. Hilsenbeck, Abhijit Mazumdar, Gordon B. Mills, Yun Zhang, Graham M. Poage, Petra den Hollander, Anna Tsimelzon, Zachary C. Hartman and Nattapon Panupinthu and has published in prestigious journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Jamal Hill

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamal Hill United States 18 620 518 260 255 166 32 1.2k
David K. Bol United States 17 681 1.1× 257 0.5× 197 0.8× 199 0.8× 159 1.0× 25 1.3k
James L. Thorne United Kingdom 23 593 1.0× 209 0.4× 355 1.4× 213 0.8× 70 0.4× 45 1.1k
Baofu Zhang China 18 652 1.1× 336 0.6× 281 1.1× 117 0.5× 225 1.4× 49 1.2k
Rubén W. Carón Argentina 16 452 0.7× 264 0.5× 187 0.7× 111 0.4× 58 0.3× 45 1.0k
Kwang Won Jeong South Korea 20 1.4k 2.2× 285 0.6× 137 0.5× 180 0.7× 129 0.8× 49 1.8k
Salvatore Panza Italy 25 838 1.4× 456 0.9× 471 1.8× 266 1.0× 134 0.8× 62 1.7k
Luisa Riccardi Italy 13 594 1.0× 433 0.8× 367 1.4× 79 0.3× 87 0.5× 15 1.4k
Jessie Liu United States 12 938 1.5× 434 0.8× 137 0.5× 138 0.5× 87 0.5× 23 1.3k
Laura Braccini Italy 8 880 1.4× 239 0.5× 273 1.1× 56 0.2× 160 1.0× 12 1.3k
Mariana S. De Lorenzo United States 19 548 0.9× 329 0.6× 272 1.0× 70 0.3× 255 1.5× 36 1.3k

Countries citing papers authored by Jamal Hill

Since Specialization
Citations

This map shows the geographic impact of Jamal Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Hill more than expected).

Fields of papers citing papers by Jamal Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamal Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Hill. The network helps show where Jamal Hill may publish in the future.

Co-authorship network of co-authors of Jamal Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Jamal Hill. A scholar is included among the top collaborators of Jamal Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamal Hill. Jamal Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Jing, Yanxia Ma, Jamal Hill, et al.. (2024). The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth. Breast Cancer Research. 26(1). 23–23. 5 indexed citations
2.
Qian, Jing, Jamal Hill, Vidyasagar Vuligonda, et al.. (2024). IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 Therapy. Clinical Cancer Research. 30(11). 2558–2570. 1 indexed citations
3.
Hill, Jamal, et al.. (2023). Abstract P004: Targeting the RXR pathway for the prevention of triple-negative breast cancer. Cancer Prevention Research. 16(1_Supplement). P004–P004. 1 indexed citations
4.
Mazumdar, Abhijit, Jamal Hill, Jitesh D. Kawedia, et al.. (2022). Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer. Cancer Prevention Research. 15(12). 791–802. 4 indexed citations
5.
Ma, Yanxia, Jonathan P. Shepherd, Dekuang Zhao, et al.. (2020). SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis. Molecular Cancer Research. 18(12). 1825–1838. 51 indexed citations
6.
Mazumdar, Abhijit, Lakshmi Reddy Bollu, Graham M. Poage, et al.. (2019). The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression. npj Breast Cancer. 5(1). 22–22. 21 indexed citations
7.
Ma, Yanxia, Jonathan H. Shepherd, Dekuang Zhao, et al.. (2018). Abstract 3347: SOX9 is a critical regulator of triple-negative breast cancer growth and invasion. Cancer Research. 78(13_Supplement). 3347–3347. 1 indexed citations
8.
Hollander, Petra den, Anna Tsimelzon, Jonathan H. Shepherd, et al.. (2016). Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival. Cancer Research. 76(7). 1942–1953. 70 indexed citations
9.
Mazumdar, Abhijit, Graham M. Poage, Jonathan H. Shepherd, et al.. (2016). Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Breast Cancer Research and Treatment. 158(3). 441–454. 22 indexed citations
10.
Hartman, Zachary C., Graham M. Poage, Petra den Hollander, et al.. (2013). Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8. Cancer Research. 73(11). 3470–3480. 341 indexed citations
11.
Abba, Martı́n C., Yuhui Hu, Sally Gaddis, et al.. (2009). Identification of Modulated Genes by Three Classes of Chemopreventive Agents at Preneoplastic Stages in a p53-Null Mouse Mammary Tumor Model. Cancer Prevention Research. 2(2). 175–184. 7 indexed citations
12.
Medina, Daniel, Frances Kittrell, Jamal Hill, et al.. (2009). Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib. Cancer Prevention Research. 2(2). 168–174. 11 indexed citations
13.
Strecker, Tracy E., Qiang Shen, Yun Zhang, et al.. (2009). Effect of Lapatinib on the Development of Estrogen Receptor–Negative Mammary Tumors in Mice. JNCI Journal of the National Cancer Institute. 101(2). 107–113. 41 indexed citations
14.
Abba, Martı́n C., Yuhui Hu, Sally Gaddis, et al.. (2008). Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models. BMC Medical Genomics. 1(1). 40–40. 11 indexed citations
15.
Li, Yi, Y. Zhang, Jamal Hill, et al.. (2008). The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice. British Journal of Cancer. 98(8). 1380–1388. 42 indexed citations
16.
Shen, Qiang, Yun Zhang, Iván P. Uray, et al.. (2006). The AP-1 transcription factor regulates postnatal mammary gland development. Developmental Biology. 295(2). 589–603. 31 indexed citations
17.
Lü, Chunhua, Corey Speers, Y. Zhang, et al.. (2003). Effect of Epidermal Growth Factor Receptor Inhibitor on Development of Estrogen Receptor-Negative Mammary Tumors. JNCI Journal of the National Cancer Institute. 95(24). 1825–1833. 73 indexed citations
18.
Dass, Narinder B., et al.. (2003). The rabbit motilin receptor: molecular characterisation and pharmacology. British Journal of Pharmacology. 140(5). 948–954. 65 indexed citations
19.
Hill, Jamal. (2003). A comparison of the effects of epidural and meperidine analgesia during labor on fetal heart rate. Obstetrics and Gynecology. 102(2). 333–337. 25 indexed citations
20.
Markaverich, Barry M., Mary Ann Alejandro, Lois A. Zitzow, et al.. (2002). Identification of an Endocrine Disrupting Agent from Corn with Mitogenic Activity. Biochemical and Biophysical Research Communications. 291(3). 692–700. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David K. Bol Breakdown of academic impact, for papers by James L. Thorne Breakdown of academic impact, for papers by Baofu Zhang Breakdown of academic impact, for papers by Rubén W. Carón Breakdown of academic impact, for papers by Kwang Won Jeong Breakdown of academic impact, for papers by Salvatore Panza Breakdown of academic impact, for papers by Luisa Riccardi Breakdown of academic impact, for papers by Jessie Liu Breakdown of academic impact, for papers by Laura Braccini Breakdown of academic impact, for papers by Mariana S. De Lorenzo
Rankless by CCL
2026